Open
Closing Soon
Capital Access Advisory Program (CAAP) — Building Companies
Support for health science companies raising capital
Last Update: April 9, 2026
Funding available
Varies by project
Timeline
- Closing date : April 30, 2026
Location
Ontario, Canada
Overview
CAAP supports health science companies preparing for a post-seed financing round. The program focuses on commercialization, fundraising, strategic planning, and closing an investment round, with participation in the OBIO Investment Summit.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Develop strategic partnerships
- Strengthen organizational capacity
- Access new markets
Eligible Funding
- Varies by project
Timeline
- Closing date : April 30, 2026
Eligible candidates
Eligible Industries
- Health care and social assistance
Location
- Ontario
Legal structures
- For-profit business
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- Startups
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Technology commercialization and investor readiness.
- Business strategic planning and fundraising preparation.
- Closing an investment round and related business development.
- Presentation at the OBIO Investment Summit.
Eligibility
Who is eligible?
- Private bioscience companies.
- Health science companies.
- Ontario-based businesses developing human health products.
Eligible geographic areas
- Ontario
Processing and Agreement
- Applications are reviewed after submission.
- Only selected companies move to the next stage.
- No further decision details are provided.
Additional information
- Applications close on April 30, 2026.
- Only selected companies will be contacted for the next stage.
- The program ends with a presentation at the OBIO Investment Summit.
Documents and links
Contacts
Frequently Asked Questions about the Capital Access Advisory Program (CAAP) — Building Companies Program
Here are answers to the most common questions about the Capital Access Advisory Program (CAAP) — Building Companies. This section explains what the program is, how much funding is available, eligibility requirements, application deadlines, and other important details to help you determine if this grant is right for your business.
What is the Capital Access Advisory Program (CAAP) — Building Companies?
CAAP supports health science companies preparing for a post-seed financing round. The program focuses on commercialization, fundraising, strategic planning, and closing an investment round, with participation in the OBIO Investment Summit.
Who is eligible for the Capital Access Advisory Program (CAAP) — Building Companies program?
To be eligible for the Capital Access Advisory Program (CAAP) — Building Companies program, you must:
Private bioscience company.
Based in Ontario.
Starting a post-seed financing round.
What expenses are eligible under Capital Access Advisory Program (CAAP) — Building Companies?
Technology commercialization and investor readiness.
Business strategic planning and fundraising preparation.
Closing an investment round and related business development.
Presentation at the OBIO Investment Summit.
Who can I contact for more information about the Capital Access Advisory Program (CAAP) — Building Companies?
You can contact Ontario Bioscience Innovation Organization (OBIO) by email at parniantajbakhsh@obio.ca or by phone at none.
Where is the Capital Access Advisory Program (CAAP) — Building Companies available?
The Capital Access Advisory Program (CAAP) — Building Companies program is available the province of Ontario.
Is the Capital Access Advisory Program (CAAP) — Building Companies a grant, loan, or tax credit?
Capital Access Advisory Program (CAAP) — Building Companies is a Other Support
Who are the financial supporters of the Capital Access Advisory Program (CAAP) — Building Companies?
Capital Access Advisory Program (CAAP) — Building Companies is funded by Ontario Bioscience Innovation Organization (OBIO)